Viral DNA Polymerase Inhibitors Market - Pipeline Insights Report 2016 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Viral DNA Polymerase Inhibitors -Pipeline Insights, 2016" report to their offering.

Viral DNA Polymerase Inhibitors-Pipeline Insights, 2016 provides in depth insights on the pipeline drugs and their development activities around the Viral DNA Polymerase Inhibitors. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.

Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.

The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Viral DNA Polymerase Inhibitors.

The report also assesses the Viral DNA Polymerase Inhibitors therapeutics by Monotherapy, Combination products, molecule type and Route of Administration.

Scope

• The report provides competitive pipeline landscape of Viral DNA Polymerase Inhibitors
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Viral DNA Polymerase Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Viral DNA Polymerase Inhibitors and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Key Topics Covered:

1. Viral DNA Polymerase Inhibitors Overview
2. Viral DNA Polymerase Inhibitors Pipeline Therapeutics
3. Viral DNA Polymerase Inhibitors Therapeutics under Development by Companies
4. Viral DNA Polymerase Inhibitors Filed and Phase III Products
5. Comparative Analysis
6. Viral DNA Polymerase Inhibitors Phase II Products
7. Comparative Analysis
8. Viral DNA Polymerase Inhibitors Phase I and IND Filed Products
9. Comparative Analysis
10. Viral DNA Polymerase Inhibitors Discovery and Pre-Clinical Stage Products
11. Comparative Analysis
12. Drug Candidate Profiles
13. Viral DNA Polymerase Inhibitors - Therapeutics Assessment
14. Assessment by Monotherapy Products
15. Assessment by Combination Products
16. Assessment by Route of Administration
17. Assessment by Molecule Type
18. Viral DNA Polymerase Inhibitors - Discontinued Products
19. Viral DNA Polymerase Inhibitors - Dormant Products
20. Companies Involved in Therapeutics Development for Viral DNA Polymerase Inhibitors

For more information visit http://www.researchandmarkets.com/research/vrcdb6/viral_dna